Premium
Cullinan Therapeutics Inc (CGEM)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | Dr. Jennifer MichaelsonChief Scientific Officer | -4,00k | 58,60k | Automatic Disposition | 14,60 - 15,58 | 166,84k | -2,34% |
| 2026-05-05 | Dr. Jennifer MichaelsonChief Scientific Officer | -4,00k | 41,20k | Derivative Exercise and Sale | 4,30 - 14,60 | 166,84k | - |
| 2026-03-05 | Dr. Jennifer MichaelsonChief Scientific Officer | -4,00k | 45,52k | Derivative Exercise and Sale | 4,30 - 15,68 | 170,84k | - |
| 2026-03-05 | Dr. Jennifer MichaelsonChief Scientific Officer | -4,00k | 62,72k | Automatic Disposition | 15,68 | 170,84k | -2,29% |
| 2026-02-25 | Dr. Jennifer MichaelsonChief Scientific Officer | -1,78k | 25,17k | Automatic Disposition | 14,14 | 174,84k | -1,01% |
| 2026-02-24 | Dr. Jennifer MichaelsonChief Scientific Officer | -3,60k | 52,11k | Vente | 14,47 | 176,62k | -2,00% |
| 2026-02-23 | Dr. Jennifer MichaelsonChief Scientific Officer | -1,75k | 24,51k | Automatic Disposition | 13,99 | 176,62k | -0,98% |
| 2026-02-24 | Ms. Jacquelyn L. SumerChief Legal Officer, CCO & Corporate Secretary | -3,60k | 52,11k | Vente | 14,47 | 53,84k | -6,27% |
| 2026-02-24 | Mr. Nadim AhmedPresident, CEO & Director | -13,52k | 195,56k | Vente | 14,47 | 148,55k | -8,34% |
| 2026-02-24 | Dr. Jeffrey JonesChief Medical Officer | -4,58k | 66,30k | Vente | 14,47 | 64,97k | -6,59% |
| 2026-02-20 | Dr. Jennifer MichaelsonChief Scientific Officer | -8,00k | 80,00k | Derivative Exercise and Sale | 4,30 - 14,30 | 181,98k | - |
| 2026-02-20 | Dr. Jennifer MichaelsonChief Scientific Officer | -3,74k | 50,97k | Vente | 13,62 | 181,98k | -2,01% |
| 2026-02-20 | Ms. Mary Kay FentonCFO | -4,40k | 59,90k | Vente | 13,62 | 126,38k | -3,36% |
| 2026-02-20 | Dr. Jeffrey JonesChief Medical Officer | -4,98k | 67,85k | Vente | 13,62 | 53,93k | -8,46% |
| 2026-02-20 | Ms. Jacquelyn L. SumerChief Legal Officer, CCO & Corporate Secretary | -3,74k | 50,97k | Vente | 13,62 | 44,94k | -7,69% |
| 2026-02-20 | Mr. Nadim AhmedPresident, CEO & Director | -16,38k | 223,11k | Vente | 13,62 | 119,80k | -12,03% |
| 2026-02-12 | Dr. Jennifer MichaelsonChief Scientific Officer | -416,00 | 5,00k | Vente | 12,03 | 28,30k | -1,45% |
| 2026-01-22 | Dr. Jennifer MichaelsonChief Scientific Officer | -4,00k | 49,20k | Automatic Disposition | 12,30 | 28,72k | -12,23% |
| 2025-12-23 | Mr. Nadim AhmedPresident, CEO & Director | -9,92k | 99,32k | Vente | 10,01 | 88,91k | -10,04% |
| 2025-12-19 | Dr. Jennifer MichaelsonChief Scientific Officer | -1,35k | 13,46k | Automatic Disposition | 10,01 | 32,72k | -3,95% |
| 2025-12-18 | Dr. Jennifer MichaelsonChief Scientific Officer | -2,90k | 28,02k | Vente | 9,67 | 34,06k | -7,84% |
| 2025-12-18 | Dr. Jeffrey JonesChief Medical Officer | -4,63k | 44,79k | Vente | 9,67 | 40,16k | -10,34% |
| 2025-12-18 | Ms. Jacquelyn L. SumerChief Legal Officer, CCO & Corporate Secretary | -3,48k | 33,65k | Vente | 9,67 | 34,22k | -9,23% |
| 2025-12-12 | Dr. Jennifer MichaelsonChief Scientific Officer | -2,15k | 26,59k | Vente | 12,38 | 36,16k | -5,61% |
| 2025-12-15 | Dr. Jennifer MichaelsonChief Scientific Officer | -995,00 | 11,84k | Automatic Disposition | 11,90 | 36,16k | -2,68% |
| 2025-11-24 | Dr. Jennifer MichaelsonChief Scientific Officer | -4,00k | 49,20k | Automatic Disposition | 12,30 | 36,69k | -9,83% |
| 2025-10-28 | Lynx1 Capital Management LPSociété | 165,67k | 1,39M | Achat | 8,40 | 8,96M | 1,88% |
| 2025-10-14 | Lynx1 Capital Management LPSociété | 248,75k | 2,10M | Achat | 7,59 - 8,86 | 8,80M | 2,91% |
| 2025-10-08 | Lynx1 Capital Management LPSociété | 1,46M | 9,83M | Achat | 6,46 - 7,36 | 8,55M | 20,59% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
